Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more
Healius Ltd - Asset Resilience Ratio
Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2017)
This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$2.43 Million | 0.06% |
| Total Liquid Assets | AU$2.43 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Healius Ltd Industry Peers by Asset Resilience Ratio
Compare Healius Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Healius Ltd (2002–2017)
The table below shows the annual Asset Resilience Ratio data for Healius Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-06-30 | 0.00% | AU$0.00 | AU$3.11 Billion | -- |
| 2016-06-30 | 0.00% | AU$0.00 | AU$3.62 Billion | -- |
| 2015-06-30 | 0.08% | AU$3.20 Million | AU$3.92 Billion | -0.04pp |
| 2012-06-30 | 0.12% | AU$4.57 Million | AU$3.86 Billion | +0.10pp |
| 2011-06-30 | 0.02% | AU$798.00K | AU$3.83 Billion | -0.02pp |
| 2010-06-30 | 0.04% | AU$1.50 Million | AU$3.70 Billion | -0.14pp |
| 2009-06-30 | 0.18% | AU$6.93 Million | AU$3.78 Billion | +0.18pp |
| 2008-06-30 | 0.00% | AU$115.00K | AU$4.80 Billion | -0.02pp |
| 2007-06-30 | 0.02% | AU$135.00K | AU$606.50 Million | +0.02pp |
| 2002-06-30 | 0.00% | AU$-6.00K | AU$283.35 Million | -- |